Detection of Hepatocyte Growth Factor (HGF) Ligand-c-MET Receptor Activation in Formalin-Fixed Paraffin Embedded Specimens by a Novel Proximity Assay
2011

Detecting Receptor Activation in Cancer Tissues

Sample size: 15 publication 10 minutes Evidence: high

Author Information

Author(s): Dua Rajiv, Zhang Jianhuan, Parry Gordon, Penuel Elicia

Primary Institution: Monogram Biosciences Inc.

Hypothesis

Can a novel proximity assay effectively measure receptor activation in formalin-fixed paraffin embedded (FFPE) tumor specimens?

Conclusion

The study presents a novel approach for detecting and quantifying ligand-receptor interactions in FFPE specimens, which can improve the reliability of receptor activation measurements.

Supporting Evidence

  • The novel proximity assay demonstrated a broad range of specificity and was consistent with independent assays.
  • c-MET and HGF levels were quantified in various cancer types, showing significant correlations with clinical outcomes.
  • The assay can detect receptor activation in archived FFPE human tissue specimens.

Takeaway

Researchers created a new test to see how certain proteins in cancer cells are activated, which can help doctors choose better treatments for patients.

Methodology

The study used antibody proximity-based assays to detect and quantify ligand-receptor complexes in FFPE specimens.

Potential Biases

Potential bias due to the use of specific antibodies that may not represent all receptor activation scenarios.

Limitations

The study may not account for all variables affecting receptor activation in clinical settings.

Participant Demographics

Human Non-Small Cell Lung Cancer (NSCLC) specimens and various cancer cell lines.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0015932

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication